Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| Genmab, Genmab’s Headquarters has moved to Toldbodgade 33 in Copenhagen |
| 24 Jul 2002 |
| Genmab, interim report 2002 | 15 Jul 2002 |
| Genmab, announces financial results for the half year ended 30 June 2002 | 15 Jul 2002 |
| Genmab, Genmab and JARI Pharmaceuticals BV to collaborate on research and development of antibody therapeutic products | 12 Jul 2002 |
| Genmab, GENMAB HuMax-IL15 effective against psoriasis in mouse study | 1 Jul 2002 |